Food and Drug Administration Modernization Act of 1997

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Food and Drug Administration Modernization Act of 1997" – news · newspapers · books · scholar · JSTOR (July 2011) (Learn how and when to remove this message)

Food and Drug Administration Modernization Act of 1997

Long title	A bill to amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to improve the regulation of food, drugs, devices, and biological products, and for other purposes.
Acronyms (colloquial)	FDAMA
Enacted by	the 105th United States Congress
Effective	November 21, 1997
Citations
Public law	105-115
Statutes at Large	111 U.S. Stat 2296
Codification
Acts amended	Federal Food, Drug and Cosmetic Act
Titles amended	Title 21 USC 301: Food and Drugs
Legislative history
Introduced in the Senate as S.830 by Sen Spencer Abraham Sen Daniel Coats Sen Christopher J. Dodd Sen William H. Frist Sen Chuck Hagel Sen James M. Jeffords Sen Connie Mack, III Sen Barbara A. Mikulski on June 5, 1997 Committee consideration by Senate Labor and Human Resources House Commerce Subcommittee on Health and Environment Signed into law by President William J. Clinton on November 21, 1997

The United States Food and Drug Administration Modernization Acts (FDAMA) are amendments to the Federal Food, Drug, and Cosmetic Act, which regulated products by the FDA. The first bill, the FDA Modernization Act of 1997, reduced the timeline for approving new pharmaceutical drugs. It also loosened rules around broadcast pharmaceutical advertising.

In 2022, the Act was updated with the FDA Modernization Act 2.0, which cancelled a 1938 mandate to require animal testing for every drug development protocol.